2022 International Congress » Parkinson's Disease: Psychiatric Manifestations

A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease

N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori (Tokyo, Japan)

Antipsychotic use in Parkinson’s disease: a single center retrospective chart review

S. Brooker, C. Yeh, D. Larson (Chicago, USA)

Apathy in Parkinson’s disease: serum biochemical markers and clinical features

LT. Li, Y. Qu, HL. Gao, YJ. Xiong, Z. Min, ZJ. Mao, JY. Li, QX. Qin, DL. Wang, JW. Zhao, Z. Xue (Wuhan, China)

Cognitive behavioral therapy for anxiety in Parkinson’s disease induces functional brain changes

G. Carey, R. Lopes, A. Moonen, A. Mulders, J. de Jong, G. Kuchcinski, L. Defebvre, M. Kuijf, K. Dujardin, A. Leentjens (Lille, France)

Defining and restoring the underlying neural circuitry of hypersexuality in Parkinson’s Disease

D. Mata-Marín, JA. Pineda-Pardo, M. Michiels, C. Pagge, C. Ammann, R. MARTíNEZ-FERNá[email protected], JA. Molina, L. Vela-Desojo, F. Alonso-Frech, JA. Obeso, I. Obeso (Móstoles, Spain)

Epidemiologic And Clinical Features Of Psychiatric Disorders In Patients With Parkinson’s Disease – A Retrospective Cohort Study

O. Koniashvili, G. Khachiashvili, L. Gabunia (Tbilisi, Georgia)

ER Visits and Hospitalizations Among Patients Treated with Pimavanserin or Other-AAPs for Parkinson’s Disease Psychosis: Analysis of Medicare beneficiaries

S. Kumar, N. Rashid, D. Doshi, K. Rajagopalan (Dover, USA)

Feasibility of using wearable sensors to monitor activity and sleep patterns in inpatients with delirium and Parkinson’s disease

G. Bate, S. Richardson, JP. Taylor, D. Burn, L. Allan, A. Yarnall, Y. Guan, S. Del-Din, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)

Illusory responses across the Lewy body disease spectrum

M. Shahid, A. Rawls, V. Ramirez, S. Ryman, V. Santini, L. Yang, S. Sha, J. Hall, T. Montine, A. Lin, L. Tian, V. Henderson, B. Cholerton, M. Yutsis, K. Poston (Palo Alto, USA)

Impulse control disorder following bilateral pallidothalamic tract focused ultrasound: a case report

S. Farrand, P. Phal, K. Fernando, A. Evans, R. Blaze (Richmond, Australia)

Longitudinal study of clinical symptoms associated with psychosis in Parkinson’s disease without dementia

J. Flanigan, M. Harrison, B. Shah, J. Patrie, K. Wyman-Chick, W. Dalrymple, S. Sperling, M. Barrett (Charlottesville, USA)

Mania induced by STN-DBS is related to the stimulation of the ventromedial subthalamic nucleus in Parkinson’s disease: a prospective study

SP. Prange, ZL. Lin, MN. Nourredine, TD. Danaila, CL. Laurencin, OLB. Lagha-Boukbiza, MA. Anheim, HK. Klinger, NL. Longato, CP. Phillipps, JV. Voirin, GP. Polo, ES. Simon, PM. Mertens, ASR. Rolland, DD. Devos, EM. Metereau, CT. Tranchant, ST. Thobois (Bron, France)

Motor-Related and Cognition-Related Safety of Pimavanserin in Patients with Parkinson’s Disease Psychosis (PDP)

V. Abler, C. Ballard, A. Berrio, B. Coate, C. Brain, A. Espay (San Diego, USA)

Neural and cognitive correlates of the co-occurrence of apathy and Impulse Control Disorder in early Parkinson’s Disease

G. Maggi, S. Costa, F. Loayza, G. Santangelo, I. Obeso (Caserta, Italy)

Neuroanatomical underpinnings of apathy in Parkinson’s Disease

C. Le Heron, E. Huey, N. Vanegas-Arroyave, Y. Gazes, S. Lee (New Zealand)

Non-Invasive Brain Stimulation for the Treatment of Psychiatric Symptoms in Parkinson’s Disease: A Systematic Review and Meta-analysis

Y. Qu (Wuhan, China)

Phantom boarder syndrome associated with experimentally-induced presence hallucinations in Parkinson’s disease

J. Potheegadoo, F. Bernasconi, O. Blanke (Geneva, Switzerland)

Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease

N. Ben Ali, M. Ben Mahmoud, E. Derbel, H. Jamoussi, S. Fray, M. Fredj (Tunis, Tunisia)

Psychosis in Parkinson’s disease and polymorphisms of the HOMER1 and COMT genes: Is there an association?

A. Lenka, S. Vadivel, R. Christopher, A. Shyam Sundar, S. Hegde, R. Yadav, P. Pal (Bangalore, India)

Reduced Risk of Mortality and Antipsychotics in Parkinson’s Disease-Related Psychosis: Pimavanserin vs Off-Label Antipsychotics

S. Isaacson, F. Pagan, D. Truong, V. Abler, R. Pahwa (Boca Raton, USA)

Regular Exercise Regimen Associated with Reduced Prevalence of Depression in Parkinson’s Disease

N. Bonsavage, A. Brown, T. Davis (Nashville, USA)

Risk of Long-term Care Admissions Among Medicare Patients Treated with Pimavanserin or Other Atypical Antipsychotics for Parkinson’s Disease Psychosis

S. Kumar, N. Rashid, D. Doshi, K. Rajagopalan (Dover, USA)

Sex-specific factor analysis-derived profile of neuropsychiatric symptoms predicting dementia conversion in Parkinson’s disease

Y. Lee, SW. Kang, SH. Yoon, K. Baik, HK. Na, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression

R. Bhome, A. Zarkali, G. Thomas, J. Iglesias, J. Cole, R. Weil (London, United Kingdom)

The 20-item Noise Pareidolia Task is uniquely sensitive to Visual Hallucinations in Parkinson’s Disease

T. Turner, F. Rodriguez-Porcel (Charleston, USA)

The effect of Deep Brain Stimulation on Sense of agency in Parkinson’s disease patients with and without impulsive compulsive behaviours.

L. Ricciardi, A. de Angelis, MP. Stenner, F. Baig, E. Pereira, S. Di Costa, MJ. Edwards, P. Haggard, F. Morgante (London, United Kingdom)